Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mickaël Marloye
Current Patent and Clinical Status of Stimulator of Interferon Genes (STING) Agonists for Cancer Immunotherapy
Pharmaceutical patent analyst
Medicine
Drug Discovery
Pharmaceutical Science
Related publications
Novel Non-Nucleotidic STING Agonists for Cancer Immunotherapy
Future Medicinal Chemistry
Drug Discovery
Molecular Medicine
Pharmacology
768 Type I Interferons Modulate Ultraviolet Radiation Induced Suppression of Immune Responses via Stimulator of Interferon Genes (STING)
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Interferon-Γ and Granulocyte/Monocyte Colony-Stimulating Factor Production by Natural Killer Cells Involves Different Signaling Pathways and the Adaptor Stimulator of Interferon Genes (STING)
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Predictive Biomarkers for Checkpoint Immunotherapy: Current Status and Challenges for Clinical Application
Cancer immunology research
Cancer Research
Immunology
APOL1-Associated Collapsing Focal Segmental Glomerulosclerosis in a Patient With Stimulator of Interferon Genes (STING)-Associated Vasculopathy With Onset in Infancy (SAVI)
American Journal of Kidney Diseases
Nephrology
Immunotherapy for Urothelial Carcinoma: Current Status and Perspectives
Cancers
Cancer Research
Oncology
Mechanisms of Transcriptional Activation of the Stimulator of Interferon Genes by Transcription Factors CREB and C-Myc
Oncotarget
Oncology
Pharmaceutical Patent Landscape for Cancer Immunotherapy: An Interview With Gilles Berger
Pharmaceutical patent analyst
Medicine
Drug Discovery
Pharmaceutical Science
Current Status of Xenotransplantation and Prospects for Clinical Application
Xenotransplantation
Transplantation
Immunology